Back to all programs Open

Sickle Cell Disease

Up to $2,000 available in assistance for Public

Check Eligibility & Apply for Sickle Cell Disease (opens in a new tab)

Eligibility & assistance

Open
Check Eligibility & Apply for Sickle Cell Disease (opens in a new tab)

Programs for those with public or federally sponsored insurance include all forms of Medicare, Medicaid, Tricare, or Veterans.

Am I likely eligible?

This is a guide, not a decision. Checking your eligibility takes a few questions and gives you an answer.

What assistance is available?

$2,000 total assistance available, shared across all types below

  • Copay
  • Medical Expenses
  • Premium
  • Travel Expense up to $500

About Sickle Cell Disease

Sickle cell disease is group of disorders that cause red blood cells to become misshapen into a sickle shape and break down. This causes the cells to die, leaving a shortage of healthy red blood cells and can block blood flow causing pain. Infections, pain, and fatigue are common symptoms.

Diagnosis Codes

Your provider uses one of these codes when confirming your diagnosis. You do not need to know your code to apply.

  • D57 Sickle-cell disorders
  • D57.0 Hb-SS disease with crisis
  • D57.00 Hb-SS disease with crisis, unspecified
  • D57.01 Hb-SS disease with acute chest syndrome
  • D57.02 Hb-SS disease with splenic sequestration
  • D57.03 Hb-SS disease with cerebral vascular involvement
  • D57.09 Hb-SS disease with crisis with other specified complication
  • D57.1 Sickle-cell disease without crisis
  • D57.2 Sickle-cell/Hb-C disease
  • D57.20 Sickle-cell/Hb-C disease without crisis
  • D57.21 Sickle-cell/Hb-C disease with crisis
  • D57.211 Sickle-cell/Hb-C disease with acute chest syndrome
  • D57.212 Sickle-cell/Hb-C disease with splenic sequestration
  • D57.213 Sickle-cell/Hb-C disease with cerebral vascular involvement
  • D57.218 Sickle-cell/Hb-C disease with crisis with other specified complication
  • D57.219 Sickle-cell/Hb-C disease with crisis, unspecified
  • D57.4 Sickle-cell thalassemia
  • D57.40 Sickle-cell thalassemia without crisis
  • D57.41 Sickle-cell thalassemia, unspecified, with crisis
  • D57.411 Sickle-cell thalassemia, unspecified, with acute chest syndrome
  • D57.412 Sickle-cell thalassemia, unspecified, with splenic sequestration
  • D57.413 Sickle-cell thalassemia, unspecified, with cerebral vascular involvement
  • D57.418 Sickle-cell thalassemia, unspecified, with crisis with other specified complication
  • D57.419 Sickle-cell thalassemia, unspecified, with crisis
  • D57.42 Sickle-cell thalassemia beta zero without crisis
  • D57.43 Sickle-cell thalassemia beta zero with crisis
  • D57.431 Sickle-cell thalassemia beta zero with acute chest syndrome
  • D57.432 Sickle-cell thalassemia beta zero with splenic sequestration
  • D57.433 Sickle-cell thalassemia beta zero with cerebral vascular involvement
  • D57.438 Sickle-cell thalassemia beta zero with crisis with other specified complication
  • D57.439 Sickle-cell thalassemia beta zero with crisis, unspecified
  • D57.44 Sickle-cell thalassemia beta plus without crisis
  • D57.45 Sickle-cell thalassemia beta plus with crisis
  • D57.451 Sickle-cell thalassemia beta plus with acute chest syndrome
  • D57.452 Sickle-cell thalassemia beta plus with splenic sequestration
  • D57.453 Sickle-cell thalassemia beta plus with cerebral vascular involvement
  • D57.458 Sickle-cell thalassemia beta plus with crisis with other specified complication
  • D57.459 Sickle-cell thalassemia beta plus with crisis, unspecified
  • D57.8 Other sickle-cell disorders
  • D57.80 Other sickle-cell disorders without crisis
  • D57.81 Other sickle-cell disorders with crisis
  • D57.811 Other sickle-cell disorders with acute chest syndrome
  • D57.812 Other sickle-cell disorders with splenic sequestration
  • D57.813 Other sickle-cell disorders with cerebral vascular involvement
  • D57.818 Other sickle-cell disorders with crisis with other specified complication
  • D57.819 Other sickle-cell disorders with crisis, unspecified

Covered Medications

The following FDA-approved medications are indicated for this condition and are covered by Accessia Health’s financial assistance program.

  • Adakveo
  • Aqvesme
  • Betibeglogene Autotemcel
  • Casgevy
  • Crizanlizumab-tmca
  • Deferiprone
  • Deferiprone (Twice Daily)
  • Droxia
  • Endari
  • Exagamglogene Autotemcel
  • Ferriprox
  • Ferriprox Twice-A-Day
  • Glutamine (Sickle Cell)
  • Hydroxyurea
  • L-Glutamine
  • Lovotibeglogene Autotemcel
  • Luspatercept-aamt
  • Lyfgenia
  • Mitapivat Sulfate
  • Oxbryta
  • Pyrukynd
  • Pyrukynd Taper Pack
  • Reblozyl
  • Siklos
  • Tepadina
  • Tepylute
  • Thiotepa
  • Thiotepa-Sodium Chloride
  • Voxelotor
  • Xromi
  • Zynteglo

Resources

These organizations offer information and support for this condition. They are independent of Accessia Health, and may not currently have assistance available for this program.

Sickle Cell Disease Association of America (SCDAA)

Sickle Cell Community Consortium

Sickle Cell 101

American Sickle Cell Anemia Association (ASCAA)

Sickle Cell Foundation of Georgia

National Alliance of Sickle Cell Centers (NASCC)

Cayenne Wellness Center & Children’s Foundation

Caregiver Resources

Aging Life Care Association

ARCH National Respite Network and Resource Center

CaringBridge

National Alliance for Caregiving

NORD

Other Patient Assistance Organizations

The Assistance Fund

Patient Advocate Foundation

Good Days

Healthwell Foundation

Ready to find out if you qualify?

Checking your eligibility takes a few questions and gives you an answer. If this program is at capacity you can join the waitlist and we will contact you when it reopens.

Check Eligibility & Apply (opens in a new tab)